CoreTIA: a modular, statistically robust transduction inhibition assay for AAV neutralization
Adeno-associated virus (AAV) gene therapy is often limited by pre-existing neutralizing antibodies (NAbs), yet current assays for NAb detection lack standardization and rarely quantify uncertainty, complicating cross-study comparisons. We present coreTIA (core Transduction Inhibition Assay), a compr...
Saved in:
| Main Authors: | Beatrix Kovács, Fanni Somogyi, Viktória Szabó, Zoltán Zsolt Nagy, István Hernádi, Ferenc Mátyás, Wim Vanduffel, Zsuzsanna Szemlaky, Balázs Rózsa, István Ulbert, Dániel Hillier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1623848/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinct infectivity and neutralization antibody responses in the highly homologous AAV Go.1 and AAV5
by: Mei Li, et al.
Published: (2025-04-01) -
Retinal Epithelial Neutralization Assay Optimizes AAV Serotype Selection for Ocular Gene Therapy
by: Yao Li, et al.
Published: (2025-07-01) -
iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy
by: Estelle Berreur, et al.
Published: (2025-06-01) -
Assessment of the Level of Virus Neutralizing Antibodies to Enterovirus 71 in Children in Ekaterinburg (2010–2017)
by: O. M. Olenkova, et al.
Published: (2019-05-01) -
Common AAV gene therapy vectors show nonselective transduction of ex vivo human brain tissue
by: JP McGinnis, et al.
Published: (2025-06-01)